Research Expert: Sarah Overall
  • Published: Mar 2025
  • Pages: 150
  • SKU: IRTNTR45363

  • Latest News- Preclinical Isolated Organ Perfusion System Market: Industrial laboratories and CROs is expected to lead the End-user segment during 2025-2029

    The Preclinical Isolated Organ Perfusion System Market is being driven by Increasing prevalence of chronic diseases

    The Preclinical Isolated Organ Perfusion System Market is expected to grow at a CAGR of 4.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 150.8 million. The global health landscape is witnessing a significant increase in the prevalence of various diseases, such as cardiovascular conditions, metabolic disorders, and cancer. This trend has spurred a surge in preclinical and clinical research activities within the pharmaceutical industry and Contract Research Organizations (CROs). The adoption of advanced omics-based technologies, including genomics, proteomics, and metabolomics, has become increasingly popular in the development of innovative therapeutic candidates. Consequently, numerous public and private funding organizations have invested substantially in drug development and research projects worldwide. This growing investment in pharmaceutical research and testing has resulted in the introduction of a multitude of new drug candidates and biosimilars into the market. 

    Get more information on Preclinical Isolated Organ Perfusion System Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • End-user
      • Industrial laboratories and CROs
      • Academic and government research institutes
    • Type
      • Isolated heart perfusion systems
      • Isolated abdominal organ perfusion systems
      • Isolated lung perfusion systems
      • Others
    • Geography
      • North America
        • Canada
        • US
      • Europe
        • Germany
        • UK
        • France
        • Italy
      • Asia
        • China
        • India
        • Japan
        • South Korea
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Increasing prevalence of chronic diseases
      • Growing demand for organ transplantation
      • Rising awareness about isolated organ research

      However, the market also witnesses some limitations, which are as follows:

      • High cost of isolated organ perfusion systems
      • Ethical concerns over use of animals in research
      • Shortage of skilled technicians regarding isolated organ perfusion system

      Benefits of Buying Global Preclinical Isolated Organ Perfusion System Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Preclinical Isolated Organ Perfusion System Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      184

      Base year

      2024

      Historic period

      2019-2023

      Forecast period

      2025-2029

      Growth momentum & CAGR

      Accelerate at a CAGR of 4.6%

      Market growth 2025-2029

      USD 150.8 million

      Market structure

      market_structure.ucfirst

      YoY growth 2024-2025(%)

      4.3

      Key countries

      US, Germany, Canada, China, Japan, UK, France, India, Italy, and South Korea

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      The Preclinical Isolated Organ Perfusion System market encompasses technologies and equipment used for the preservation and function assessment of organs, including the lung, kidney, brain, and heart, through techniques like Isolated Organ Perfusion. Applications include chemotherapy, organ transplantation, and research in cardiovascular diseases such as stroke, disability, and coronary artery disease. The market caters to both public and private healthcare sectors, offering solutions like cardiopulmonary perfusion systems, cell perfusion systems, heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and hypothermic and normothermic machine perfusion systems for drugs, healthcare products, organ donation, cell-based research, and biologics manufacturing.

      Market Research Overview

      The Preclinical Isolated Organ Perfusion System market is a segment of the larger Life Science Tools and Services industry. This sector encompasses organizations involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized for the advancement of pharmaceuticals, biotechnology products, and laboratory diagnosis of diseases. The market size is determined by the consolidated revenue generated from the sales of equipment, supplies, pharmaceuticals, biotechnology, and life science services. Factors driving growth in this sector include the increasing global population aging, with a predicted rise in individuals over 60 years, leading to a greater demand for healthcare solutions. Additionally, the market will be propelled by advancements in organ perfusion technology for organs such as the lung, kidney, and brain, as well as the application of this technology in chemotherapy and organ transplantation processes.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.